Ascelia Pharma AB (publ) (STO:ACE)
Sweden
· Delayed Price · Currency is SEK 3.800
+0.200 (5.56%)
May 5, 2025, 4:59 PM CET
Ascelia Pharma AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Net Income | -80.03 | -109.29 | -131.22 | -125.9 | -98.7 | Upgrade
|
| Depreciation & Amortization | 0.94 | 1.05 | 1.05 | 1.03 | 0.83 | Upgrade
|
| Stock-Based Compensation | 4.34 | 2.93 | 1.63 | 5.92 | 7.87 | Upgrade
|
| Other Operating Activities | 8.38 | 0.35 | -11.38 | -11.08 | 5.17 | Upgrade
|
| Change in Accounts Receivable | -4.99 | 1.62 | -1.36 | -0.9 | 1.7 | Upgrade
|
| Change in Accounts Payable | 3.21 | -14.35 | 9.72 | 2.26 | -1.22 | Upgrade
|
| Change in Other Net Operating Assets | 5.31 | -9.11 | 6.31 | 12.11 | -1.17 | Upgrade
|
| Operating Cash Flow | -62.84 | -126.79 | -125.26 | -116.56 | -85.53 | Upgrade
|
| Capital Expenditures | - | - | - | -0.04 | -0.4 | Upgrade
|
| Investment in Securities | - | - | - | - | 76.39 | Upgrade
|
| Other Investing Activities | - | 0.05 | -0.07 | - | - | Upgrade
|
| Investing Cash Flow | - | 0.05 | -0.07 | -0.04 | 75.99 | Upgrade
|
| Short-Term Debt Issued | 32.73 | - | - | - | - | Upgrade
|
| Long-Term Debt Issued | 0.73 | - | - | - | - | Upgrade
|
| Total Debt Issued | 33.46 | - | - | - | - | Upgrade
|
| Short-Term Debt Repaid | -7.5 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -0.89 | -0.91 | -1.02 | -0.94 | -0.64 | Upgrade
|
| Total Debt Repaid | -8.39 | -0.91 | -1.02 | -0.94 | -0.64 | Upgrade
|
| Net Debt Issued (Repaid) | 25.07 | -0.91 | -1.02 | -0.94 | -0.64 | Upgrade
|
| Issuance of Common Stock | 105.32 | - | 0.3 | 200.4 | 98.65 | Upgrade
|
| Repurchase of Common Stock | - | - | -0.3 | -0.4 | - | Upgrade
|
| Other Financing Activities | -15.21 | -0.03 | -0.08 | -14.19 | -5.29 | Upgrade
|
| Financing Cash Flow | 115.19 | -0.94 | -1.1 | 184.87 | 92.73 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1.06 | -0.02 | 14.38 | 8.64 | -7.02 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | -0 | - | - | - | Upgrade
|
| Net Cash Flow | 53.4 | -127.7 | -112.04 | 76.91 | 76.17 | Upgrade
|
| Free Cash Flow | -62.84 | -126.79 | -125.26 | -116.6 | -85.92 | Upgrade
|
| Free Cash Flow Per Share | -1.16 | -3.76 | -3.60 | -3.54 | -3.27 | Upgrade
|
| Cash Interest Paid | 5.22 | 0.12 | 0.05 | 0.08 | 0.09 | Upgrade
|
| Cash Income Tax Paid | -1.45 | -1.17 | -3.77 | -1.02 | 0.09 | Upgrade
|
| Levered Free Cash Flow | -16.1 | -87 | -74.73 | -74.23 | -48.32 | Upgrade
|
| Unlevered Free Cash Flow | -13.78 | -87 | -74.7 | -74.18 | -48.31 | Upgrade
|
| Change in Net Working Capital | -23.52 | 21.31 | -14.92 | -5.09 | -1.68 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.